As Annual Recurring Revenue Accelerates, CrowdStrike Buy?
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,572 articlesCrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
When a promising growth stock pulls back 21% from its recent high, many investors hesitate. This guide shows how to v...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
From public housing in Brooklyn to Harvard at 16 and a 12-year Goldman Sachs tenure, the former Goldman Sachs leader ...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
A sizable stake emerged as H&R Block faced a meaningful slide. This article breaks down what a block stock down inves...
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
Vitalik Buterin unveiled a three-part framework for Ethereum, aiming to reshape the network’s use case and potentiall...
Toyota is recalling approximately 550,000 Highlander and Highlander Hybrid SUVs over a seat-lock defect that could mo...
Nvidia’s slip headlines a cautious mood as GTC 2026 approaches. This deep dive explores what it means for tech stocks...
Gold climbs to new highs while Bitcoin retreats, setting the stage for a heated five-year debate on which asset shoul...